Literature DB >> 34120185

SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.

.   

Abstract

AIMS: The aim of this study was to derive and validate the SCORE2-Older Persons (SCORE2-OP) risk model to estimate 5- and 10-year risk of cardiovascular disease (CVD) in individuals aged over 70 years in four geographical risk regions. METHODS AND
RESULTS: Sex-specific competing risk-adjusted models for estimating CVD risk (CVD mortality, myocardial infarction, or stroke) were derived in individuals aged over 65 without pre-existing atherosclerotic CVD from the Cohort of Norway (28 503 individuals, 10 089 CVD events). Models included age, smoking status, diabetes, systolic blood pressure, and total- and high-density lipoprotein cholesterol. Four geographical risk regions were defined based on country-specific CVD mortality rates. Models were recalibrated to each region using region-specific estimated CVD incidence rates and risk factor distributions. For external validation, we analysed data from 6 additional study populations {338 615 individuals, 33 219 CVD validation cohorts, C-indices ranged between 0.63 [95% confidence interval (CI) 0.61-0.65] and 0.67 (0.64-0.69)}. Regional calibration of expected-vs.-observed risks was satisfactory. For given risk factor profiles, there was substantial variation across the four risk regions in the estimated 10-year CVD event risk.
CONCLUSIONS: The competing risk-adjusted SCORE2-OP model was derived, recalibrated, and externally validated to estimate 5- and 10-year CVD risk in older adults (aged 70 years or older) in four geographical risk regions. These models can be used for communicating the risk of CVD and potential benefit from risk factor treatment and may facilitate shared decision-making between clinicians and patients in CVD risk management in older persons. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  10-Year CVD risk; Cardiovascular disease; Older persons; Primary prevention; Risk assessment; Risk prediction

Mesh:

Year:  2021        PMID: 34120185      PMCID: PMC8248997          DOI: 10.1093/eurheartj/ehab312

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   35.855


  46 in total

1.  Random measurement error and regression dilution bias.

Authors:  Jennifer A Hutcheon; Arnaud Chiolero; James A Hanley
Journal:  BMJ       Date:  2010-06-23

2.  Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sandeep R Das; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Carmen R Isasi; Monik C Jiménez; Suzanne E Judd; Brett M Kissela; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David J Magid; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Wayne Rosamond; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2016-01-26       Impact factor: 29.690

3.  Competing risk of death: an important consideration in studies of older adults.

Authors:  Sarah D Berry; Long Ngo; Elizabeth J Samelson; Douglas P Kiel
Journal:  J Am Geriatr Soc       Date:  2010-03-22       Impact factor: 5.562

4.  Use and misuse of the receiver operating characteristic curve in risk prediction.

Authors:  Nancy R Cook
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

5.  Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology.

Authors:  Donald M Lloyd-Jones; Mark D Huffman; Kunal N Karmali; Darshak M Sanghavi; Janet S Wright; Colleen Pelser; Martha Gulati; Frederick A Masoudi; David C Goff
Journal:  J Am Coll Cardiol       Date:  2016-11-04       Impact factor: 24.094

6.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

7.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

Authors:  Jackson T Wright; Jeff D Williamson; Paul K Whelton; Joni K Snyder; Kaycee M Sink; Michael V Rocco; David M Reboussin; Mahboob Rahman; Suzanne Oparil; Cora E Lewis; Paul L Kimmel; Karen C Johnson; David C Goff; Lawrence J Fine; Jeffrey A Cutler; William C Cushman; Alfred K Cheung; Walter T Ambrosius
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245

8.  Estimating treatment effects for individual patients based on the results of randomised clinical trials.

Authors:  Johannes A N Dorresteijn; Frank L J Visseren; Paul M Ridker; Annemarie M J Wassink; Nina P Paynter; Ewout W Steyerberg; Yolanda van der Graaf; Nancy R Cook
Journal:  BMJ       Date:  2011-10-03

9.  Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study.

Authors:  Wouter de Ruijter; Rudi G J Westendorp; Willem J J Assendelft; Wendy P J den Elzen; Anton J M de Craen; Saskia le Cessie; Jacobijn Gussekloo
Journal:  BMJ       Date:  2009-01-08

10.  Cohort profile: cohort of Norway (CONOR).

Authors:  Oyvind Naess; Anne Johanne Søgaard; Egil Arnesen; Anne Cathrine Beckstrøm; Espen Bjertness; Anders Engeland; Peter F Hjort; Jostein Holmen; Per Magnus; Inger Njølstad; Grethe S Tell; Lars Vatten; Stein Emil Vollset; Geir Aamodt
Journal:  Int J Epidemiol       Date:  2007-11-04       Impact factor: 7.196

View more
  18 in total

Review 1.  Implications of the heterogeneity between guideline recommendations for the use of low dose aspirin in primary prevention of cardiovascular disease.

Authors:  Xiao-Ying Li; Li Li; Sang-Hoon Na; Francesca Santilli; Zhongwei Shi; Michael Blaha
Journal:  Am J Prev Cardiol       Date:  2022-06-06

2.  Socioeconomic Deprivation: An Important, Largely Unrecognized Risk Factor in Primary Prevention of Cardiovascular Disease.

Authors:  Dorien M Kimenai; Leah Pirondini; John Gregson; David Prieto; Stuart J Pocock; Pablo Perel; Tilly Hamilton; Paul Welsh; Archie Campbell; David J Porteous; Caroline Hayward; Naveed Sattar; Nicholas L Mills; Anoop S V Shah
Journal:  Circulation       Date:  2022-06-24       Impact factor: 39.918

3.  Cholesterol and Hypertension Treatment Improve Coronary Risk Prediction but Not Time-Dependent Covariates or Competing Risks.

Authors:  Isaac Subirana; Anna Camps-Vilaró; Roberto Elosua; Jaume Marrugat; Helena Tizón-Marcos; Ivan Palomo; Irene R Dégano
Journal:  Clin Epidemiol       Date:  2022-10-11       Impact factor: 5.814

4.  Prognostic Value of a Polygenic Risk Score for Coronary Heart Disease in Individuals Aged 70 Years and Older.

Authors:  Johannes T Neumann; Moeen Riaz; Andrew Bakshi; Galina Polekhina; Le T P Thao; Mark R Nelson; Robyn L Woods; Gad Abraham; Michael Inouye; Christopher M Reid; Andrew M Tonkin; John McNeil; Paul Lacaze
Journal:  Circ Genom Precis Med       Date:  2021-12-24

Review 5.  Innovative Approaches to Assess Intermediate Cardiovascular Risk Subjects: A Review From Clinical to Metabolomics Strategies.

Authors:  Aline M A Martins; Mariana U B Paiva; Diego V N Paiva; Raphaela M de Oliveira; Henrique L Machado; Leonardo J S R Alves; Carolina R C Picossi; Andréa T Faccio; Marina F M Tavares; Coral Barbas; Viviane Z R Giraldez; Raul D Santos; Guilherme U Monte; Fernando A Atik
Journal:  Front Cardiovasc Med       Date:  2021-12-22

6.  Usefulness of Cardiac Computed Tomography in Coronary Risk Prediction: A Five-Year Follow-Up of the SPICA Study (Secure Prevention with Imaging of the Coronary Arteries).

Authors:  David Viladés-Medel; Irene R Dégano; Isaac Subirana; Martin Descalzo; Mireia Padilla; Xavier Mundet; Francesc Carreras Costa; Xavier Alomar Serrallach; Anna Camps; Roberto Elosua; Jaume Marrugat; Rubén Leta Petracca
Journal:  J Clin Med       Date:  2022-01-21       Impact factor: 4.241

7.  Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study.

Authors:  Shona J Livingstone; Bruce Guthrie; Peter T Donnan; Alexander Thompson; Daniel R Morales
Journal:  BMC Med       Date:  2022-05-04       Impact factor: 11.150

8.  SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.

Authors: 
Journal:  Eur Heart J       Date:  2021-07-01       Impact factor: 35.855

9.  Editorial: The 2021 European Society of Cardiology (ESC) Guidelines on the Real-World Prevention of Atherosclerotic Cardiovascular Disease (ASCVD).

Authors:  Dinah V Parums
Journal:  Med Sci Monit       Date:  2021-10-25

Review 10.  Strategies for Sudden Cardiac Death Prevention.

Authors:  Mattia Corianò; Francesco Tona
Journal:  Biomedicines       Date:  2022-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.